Zhang et al., 1992 - Google Patents
Human T Lymphotropic Virus Types 1-and II-Specific Antibody-Dependent Cellular Cytotoxicity: Strain Specificity and Epitope MappingZhang et al., 1992
- Document ID
- 11014080452754112883
- Author
- Zhang X
- Yang L
- Ho D
- Kuritzkes D
- Chen I
- Ching W
- Chen Y
- Schooley R
- Publication year
- Publication venue
- Journal of Infectious Diseases
External Links
Snippet
Antibody-dependent cellular cytotoxicity (ADCC) against human T lymphotropic virus (HTLV) types I and II was investigated using sera obtained from infected individuals or from rabbits immunized with HTLV-I or-II envelope peptides. Target cells included an HTLV-I-transformed …
- 230000010056 antibody-dependent cellular cytotoxicity 0 title abstract description 79
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
- C07K16/1036—Retroviridae, e.g. leukemia viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lifson et al. | Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein | |
| LYERLY et al. | Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC | |
| Weiss et al. | Variable and conserved neutralization antigens of human immunodeficiency virus | |
| Lipka et al. | Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes | |
| Koup et al. | Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs | |
| Kikuta et al. | Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease | |
| Belshe et al. | Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection | |
| Koup et al. | Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera | |
| Ikuta et al. | Expression of human immunodeficiency virus type 1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens | |
| US5550052A (en) | Hybrid cell line formed between T4 lymphocytes and tumoral lymphoid type cells | |
| Blumberg et al. | Antibody-dependent cell-mediated cytotoxicity against cells infected with the human immunodeficiency virus | |
| Krohn et al. | Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men. | |
| KR100482616B1 (en) | Multi-subtype fiv vaccines | |
| ICHIMURA et al. | Biological, serological, and genetic characterization of HIV-1 subtype E isolates from northern Thailand | |
| Torpey III et al. | Effects of adoptive immunotherapy with autologous CD8+ T lymphocytes on immunologic parameters: lymphocyte subsets and cytotoxic activity | |
| US7122188B1 (en) | Antibodies which bind with proteins of human immunodeficiency virus type 1 (HIV-1), and immune complexes comprising proteins of HIV-1 | |
| Buckner et al. | Immune responsiveness to the immunodominant recombinant envelope epitopes of human T lymphotropic virus types I and II in diverse geographic populations | |
| MAUCLERE et al. | A new HTLV type II subtype A isolate in an HIV type 1-infected prostitute from Cameroon, Central Africa | |
| Zhang et al. | Human T Lymphotropic Virus Types 1-and II-Specific Antibody-Dependent Cellular Cytotoxicity: Strain Specificity and Epitope Mapping | |
| Albert et al. | Ugandan HIV-1 V3 loop sequences closely related to the US/European consensus | |
| AU641554B2 (en) | Novel peptide antigens and immunoassays, test kits and vaccines using the same | |
| Astier-Gin et al. | Neutralizing activity and antibody reactivity toward immunogenic regions of the human T cell leukemia virus type I surface glycoprotein in sera of infected patients with different clinical states | |
| Blazevic et al. | Helper T-cell recognition of HIV-1 Tat synthetic peptides | |
| EP0260714B1 (en) | The use of activated t-lymphocytes for preparing a pharmaceutical composition for the treatment of AIDS | |
| Bugge et al. | Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody |